JP2011520894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520894A5 JP2011520894A5 JP2011509615A JP2011509615A JP2011520894A5 JP 2011520894 A5 JP2011520894 A5 JP 2011520894A5 JP 2011509615 A JP2011509615 A JP 2011509615A JP 2011509615 A JP2011509615 A JP 2011509615A JP 2011520894 A5 JP2011520894 A5 JP 2011520894A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administered
- rhcc10
- composition according
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5286108P | 2008-05-13 | 2008-05-13 | |
| US61/052,861 | 2008-05-13 | ||
| PCT/US2009/043613 WO2009140269A2 (en) | 2008-05-13 | 2009-05-12 | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011520894A JP2011520894A (ja) | 2011-07-21 |
| JP2011520894A5 true JP2011520894A5 (https=) | 2012-06-21 |
| JP5773437B2 JP5773437B2 (ja) | 2015-09-02 |
Family
ID=41319290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509615A Expired - Fee Related JP5773437B2 (ja) | 2008-05-13 | 2009-05-12 | 鼻性鼻炎の治療に使用するための組換えヒトｃｃ１０およびその組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20110240012A1 (https=) |
| EP (2) | EP3085382A1 (https=) |
| JP (1) | JP5773437B2 (https=) |
| KR (1) | KR20110014199A (https=) |
| CN (1) | CN102292099A (https=) |
| AU (1) | AU2009246543B2 (https=) |
| BR (1) | BRPI0911945A2 (https=) |
| CA (1) | CA2724277A1 (https=) |
| IL (1) | IL208940A0 (https=) |
| MX (1) | MX2010012234A (https=) |
| NZ (2) | NZ600803A (https=) |
| WO (1) | WO2009140269A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060281681A1 (en) | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| NZ600803A (en) | 2008-05-13 | 2013-12-20 | Clarassance Inc | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis |
| US9168285B2 (en) | 2009-10-15 | 2015-10-27 | Therabron Therapeutics, Inc. | Recombinant human CC10 protein for treatment of influenza and ebola |
| MX2012004409A (es) * | 2009-10-15 | 2012-08-23 | Clarassance Inc | Proteina recombinante de humano cc10 para el tratamiento de la influenza. |
| WO2012170842A2 (en) | 2011-06-09 | 2012-12-13 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Peptide for protection of allergic respiratory disorders |
| WO2014106021A1 (en) | 2012-12-27 | 2014-07-03 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with p-glycoprotein inhibitors |
| PE20200404A1 (es) * | 2013-03-15 | 2020-02-26 | Janssen Pharmaceutica Nv | Composicion farmaceutica de clorhidrato de s-ketamina |
| WO2016205430A1 (en) * | 2015-06-15 | 2016-12-22 | Therabron Therapeutics, Inc. | Recombinant human cc10 protein facilitates repair and protects against damage to the respiratory epithelium due to exposure to both cigarette and other smoke |
| WO2017123933A1 (en) | 2016-01-15 | 2017-07-20 | Massachusetts Eye And Ear Infirmary | Secreted p-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis |
| EP3930808A4 (en) * | 2019-02-27 | 2022-12-14 | Oticara, Inc. | METHODS OF TREATMENT OF NASAL, SINONASAL AND NASOPHARYNGEAL TISSUE INFECTION AND/OR INFLAMMATION |
| MX2021010683A (es) | 2019-03-05 | 2021-12-10 | Janssen Pharmaceuticals Inc | Esketamina para el tratamiento de la depresión. |
| US12295933B2 (en) | 2019-03-25 | 2025-05-13 | Massachusetts Eye And Ear Infirmary | Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4691009A (en) | 1984-12-26 | 1987-09-01 | Repligen Corporation | Hybrid proteins produced by an ultrahigh prokaryotic expression system |
| WO1987002367A2 (en) | 1985-10-18 | 1987-04-23 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
| US4820514A (en) | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
| JP2656944B2 (ja) | 1987-04-30 | 1997-09-24 | クーパー ラボラトリーズ | タンパク質性治療剤のエアロゾール化 |
| US5266562A (en) | 1987-11-19 | 1993-11-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-inflammatory agents |
| US5354269A (en) | 1991-12-20 | 1994-10-11 | Fibrogenex, Inc. | Method for treating cancer resections |
| US5491130A (en) | 1992-11-10 | 1996-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide inhibitors of fibronectin and related collagen-binding proteins |
| US5482930A (en) | 1993-06-09 | 1996-01-09 | The Regents Of The University Of California | Anti-inflammatory composition and method with des-Tyr dynorphin and analogues |
| US5470885A (en) | 1993-09-29 | 1995-11-28 | The Research Foundation Of The State University Of New York | Fluorocarbons as anti-inflammatory agents |
| FR2724665B1 (fr) | 1994-09-16 | 1996-12-20 | Rhone Poulenc Rorer Sa | Procede de production de proteines recombinantes, plasmides et cellules modifiees |
| US5696092A (en) | 1995-03-07 | 1997-12-09 | George Washington University | Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers |
| US5935860A (en) | 1995-03-07 | 1999-08-10 | The George Washington University | Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia |
| WO1997001627A1 (en) | 1995-06-27 | 1997-01-16 | Igen International, Inc. | High-level expression and efficient recovery of ubiquitin fusion proteins from escherichia coli |
| US5817750A (en) | 1995-08-28 | 1998-10-06 | La Jolla Cancer Research Foundation | Structural mimics of RGD-binding sites |
| CA2248136A1 (en) | 1996-03-21 | 1997-09-25 | Human Genome Sciences, Inc. | Human endometrial specific steroid-binding factor i, ii and iii |
| AU5253998A (en) | 1996-11-13 | 1998-06-03 | Board Of Regents, The University Of Texas System | Diminishing viral gene expression by promoter replacement |
| US6255281B1 (en) | 1997-05-28 | 2001-07-03 | Claragen, Inc. And U.S. Government | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| US20030008816A1 (en) | 1997-05-28 | 2003-01-09 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20030207795A1 (en) | 1997-05-28 | 2003-11-06 | Pilon Aprile L. | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| US20040047857A1 (en) | 1997-05-28 | 2004-03-11 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US7122344B2 (en) | 1997-05-28 | 2006-10-17 | Claragen, Inc. | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| US20060025348A1 (en) | 1997-05-28 | 2006-02-02 | Pilon Aprile L | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20050261180A1 (en) | 1997-05-28 | 2005-11-24 | Pilon Aprile L | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| US20020169108A1 (en) | 1997-05-28 | 2002-11-14 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20060281681A1 (en) | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| US20020160948A1 (en) | 1998-07-21 | 2002-10-31 | Aprile Pilon | Recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| DE69939165D1 (de) | 1998-04-16 | 2008-09-04 | Encysive Pharmaceuticals Inc | N,n-disubstituierte amide welche die bindung von integrinen an ihre rezeptoren hemmen |
| AU5836700A (en) | 1999-06-01 | 2000-12-18 | Patrick T. Prendergast | Peptides for therapeutic use |
| JP2003512856A (ja) | 1999-11-04 | 2003-04-08 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ウテログロビン様ポリヌクレオチド、ポリペプチド、および抗体 |
| WO2001079285A1 (en) | 2000-04-14 | 2001-10-25 | Claragen, Inc. | Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production |
| US20020025510A1 (en) | 2000-07-26 | 2002-02-28 | Strongin Alex Y. | Screening methods based on superactivated alpha V beta 3 integrin |
| WO2003057257A1 (en) * | 2002-01-02 | 2003-07-17 | The Johns Hopkins University | Cc10 inhibits th2 cytokines and eotaxins involved in allergic diseases |
| US20090227025A1 (en) | 2003-06-06 | 2009-09-10 | The Board Of Regents Of The University Of Texas System | Ex vivo human lung/immune system model using tissue engineering for studying microbial pathogens with lung tropism |
| KR101380200B1 (ko) * | 2004-08-12 | 2014-04-01 | 헬신 세라퓨틱스 (유.에스.) 인크. | 성장 호르몬 분비촉진제를 이용하여 위장관계의 운동성을촉진하는 방법 |
| WO2008066644A1 (en) * | 2006-11-02 | 2008-06-05 | Riolan Technologies, Inc. | Methods of treating epiphora |
| EP1935242A1 (en) * | 2006-12-21 | 2008-06-25 | Philip Morris Products S.A. | Transgenic animal model |
| US20090253174A1 (en) | 2008-04-08 | 2009-10-08 | Zach Serber | Expression of Heterologous Sequences |
| NZ600803A (en) | 2008-05-13 | 2013-12-20 | Clarassance Inc | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis |
| MX2012004409A (es) | 2009-10-15 | 2012-08-23 | Clarassance Inc | Proteina recombinante de humano cc10 para el tratamiento de la influenza. |
-
2009
- 2009-05-12 NZ NZ600803A patent/NZ600803A/en not_active IP Right Cessation
- 2009-05-12 EP EP16164414.1A patent/EP3085382A1/en not_active Withdrawn
- 2009-05-12 NZ NZ588895A patent/NZ588895A/en not_active IP Right Cessation
- 2009-05-12 CN CN2009801169194A patent/CN102292099A/zh active Pending
- 2009-05-12 AU AU2009246543A patent/AU2009246543B2/en not_active Ceased
- 2009-05-12 WO PCT/US2009/043613 patent/WO2009140269A2/en not_active Ceased
- 2009-05-12 JP JP2011509615A patent/JP5773437B2/ja not_active Expired - Fee Related
- 2009-05-12 BR BRPI0911945A patent/BRPI0911945A2/pt not_active IP Right Cessation
- 2009-05-12 EP EP09747353A patent/EP2303308A4/en not_active Ceased
- 2009-05-12 CA CA2724277A patent/CA2724277A1/en not_active Abandoned
- 2009-05-12 KR KR1020107028003A patent/KR20110014199A/ko not_active Ceased
- 2009-05-12 MX MX2010012234A patent/MX2010012234A/es active IP Right Grant
-
2010
- 2010-10-26 IL IL208940A patent/IL208940A0/en unknown
- 2010-11-12 US US12/945,622 patent/US20110240012A1/en not_active Abandoned
-
2016
- 2016-02-12 US US15/042,790 patent/US9844580B2/en active Active
-
2017
- 2017-11-10 US US15/809,357 patent/US20180125931A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520894A5 (https=) | ||
| JP5773437B2 (ja) | 鼻性鼻炎の治療に使用するための組換えヒトｃｃ１０およびその組成物 | |
| Videler et al. | Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study | |
| AU2010335594B2 (en) | Synergistic antiviral composition and use thereof | |
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| JP2008044951A5 (https=) | ||
| BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
| NZ606383A (en) | Methods of treating pulmonary disorders with liposomal amikacin formulations | |
| PL2043637T3 (pl) | Sposoby i leki do podawania ibuprofenu | |
| EP4609912A3 (en) | New use of a combination of sacubitril and valsartan | |
| WO2011094504A4 (en) | Antimicrobial sinus irrigation compositions, methods, and devices | |
| HRP20181079T1 (hr) | Sirnk i njena primjena u metodama i kompozicijama za liječenje i/ili prevenciju očnih stanja | |
| CN108472375A (zh) | 中重度流感的治疗方法 | |
| US10959964B2 (en) | Use of a sprayable composition comprising ambroxol | |
| JP5572110B2 (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
| CN101361857A (zh) | 一种鼻腔表面制剂 | |
| CN101947229A (zh) | 一种用于治疗鼻炎的药物组合物 | |
| FI3976012T3 (fi) | Ketamiinin intranasalinen annostus klusteripäänsärkypotilaille | |
| CN107638468A (zh) | 一种用于治疗慢性鼻炎的中药组合物及其用途 | |
| CN1242744C (zh) | 一种治疗常年性变态反应鼻炎的鼻腔制剂 | |
| JP2010519274A5 (https=) | ||
| TW201249427A (en) | Use of sprayable composition containing ambroxol | |
| RU2023125283A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| JP2015512439A5 (https=) | ||
| HRP20191847T1 (hr) | Sastav antitijela protiv il-17ra i terapijski režimi za liječenje psorijaze |